Illumina, Inc. SEC filings ILMN
Illumina, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Feb 14, 2019. Its latest annual report, Form ARS, was filed on Apr 9, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 30, 2026, covering the quarter ended Sep 27, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (results of operations). The company's fiscal year ends on January 3.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 9, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Feb 12, 2026 | Dec 28, 2025 |
| ARS | Annual report to shareholders | Apr 9, 2025 | Dec 29, 2024 |
| 10-K | Annual report | Feb 12, 2025 | Dec 29, 2024 |
| ARS | Annual report to shareholders | Apr 4, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 16, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 20, 2023 | Jan 1, 2023 |
| 10-K | Annual report | Feb 17, 2023 | Jan 1, 2023 |
| 10-K | Annual report | Feb 18, 2022 | Jan 2, 2022 |
| 10-K | Annual report | Feb 17, 2021 | Jan 3, 2021 |
| 10-K | Annual report | Feb 11, 2020 | Dec 29, 2019 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- ILMN (Nasdaq)
- Fiscal year ends
- January 3
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1110803
- Former names
- ILLUMINA INC (until Aug 19, 2019)
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
- 10x Genomics, Inc. TXG
Source: SEC EDGAR filings. This is company-reported data, not investment advice.